| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/07/1993 | EP0535463A1 Imidazolpropen acid derivatives as angiotensin II antagonists |
| 04/07/1993 | EP0535446A1 Pharmaceutical compositions for topical use containing a chelating agent, a tocopheral and an antimicrobial agent |
| 04/07/1993 | EP0535440A2 The use of L-carnitine in endangered pregnancy |
| 04/07/1993 | EP0535420A1 Imidazol-5-carbon acid derivatives acylales as angiotensin II inhibitors |
| 04/07/1993 | EP0535390A1 The use of L-2-oxothiazolidine-4-carboxylate for the preparation of a medicament for treating latent HIV infection |
| 04/07/1993 | EP0535346A1 9-amino-7-substituted-6-demethyl-6-deoxytetracyclines |
| 04/07/1993 | EP0535327A1 Pharmaceutical composition containing felbinac |
| 04/07/1993 | EP0535283A1 Cardioprotective tocopherol analogs |
| 04/07/1993 | EP0535269A1 Pharmaceutical compositions containing thiazolidinedione derivatives |
| 04/07/1993 | EP0535256A1 Substituted 1-phenyl-1-benzoylamino-5-aminopentanes, their preparation and use |
| 04/07/1993 | EP0535250A1 Novel compounds and use thereof as medicine |
| 04/07/1993 | EP0535231A1 Pyrimidine nucleoside derivative |
| 04/07/1993 | EP0535200A1 Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use |
| 04/07/1993 | EP0535184A1 Novel quinolones, process for their preparation and pharmaceutical compositions containing same |
| 04/07/1993 | EP0535111A1 Transdermal administration of buprenorphine |
| 04/07/1993 | EP0535081A1 Substituted benzimidazoles, process for their preparation and their pharmaceutical use |
| 04/07/1993 | EP0535034A1 Pharmaceutically active benzoquinazoline compounds |
| 04/07/1993 | EP0535021A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 04/07/1993 | EP0535001A1 Composite molecular system for the contra-escalatory treatment of viral infections. |
| 04/07/1993 | EP0532674A4 Leukotriene antagonists |
| 04/07/1993 | EP0513200A4 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/07/1993 | EP0311640B1 Higher alkyl pyrrolidone extractants for water soluble phenolic or carboxylic antibiotics |
| 04/07/1993 | EP0256036B1 Production and use of purpurins, chlorins and purpurin- and chlorin-containing compositions |
| 04/07/1993 | CN1070646A Imidazo-fused iso-and heterocycles, process for their preparation, compositions containing them and their use |
| 04/07/1993 | CN1070645A Imidazolyl-alkenoic acids |
| 04/07/1993 | CN1070644A 3,4-dehydropiperidine derivatives |
| 04/07/1993 | CN1070642A Process for preparation of anti-hypercholesterolemic |
| 04/07/1993 | CN1070637A 3-cycloalkyl-prop-2-enamide derivatives |
| 04/07/1993 | CN1070568A Production method of oral xanthogenic acid as medicine |
| 04/06/1993 | USH1168 Antiinflammatory agent for improving tissue and body organ recovering from bacteria infection consisting of lipid analoges in carrier |
| 04/06/1993 | US5200553 Biologically active carboxylic acid esters |
| 04/06/1993 | US5200550 Administering for dermatologic, rheumatismal, respiratory or ophthalomologic disorders |
| 04/06/1993 | US5200536 Fluorine-containing vitamin D3 analogues |
| 04/06/1993 | US5200531 Condensing alkoxyfuranone with benzaldehyde in mixture of dipolar aprotic solvent and protic solvent using lithium hydroxide catalyst, precipitating with water, removing solvent |
| 04/06/1993 | US5200525 Antiepileptic agents |
| 04/06/1993 | US5200515 5'-trifluoromethyl-2'-deoxy-uridine phospholipid compounds |
| 04/06/1993 | US5200453 Preservative for ophthalmic solutions |
| 04/06/1993 | US5200429 Acne vulgaris treating |
| 04/06/1993 | US5200428 Enzyme inhibitors |
| 04/06/1993 | US5200426 Preventing the growth or differentiation of common acute lymphoblastic leukemia antigen and human leukemia cells |
| 04/06/1993 | US5200424 Use of 10-membered ring lactones as lipid regulators |
| 04/06/1993 | US5200423 Amine derivatives, processes for preparing the same and fungicides containing the same |
| 04/06/1993 | US5200420 2,6-dialkyl-4-(benzothiazol- or benzoxazol-4-yl-1,4-dihydropyridines |
| 04/06/1993 | US5200418 Cryptosporidiosis amelioration |
| 04/06/1993 | US5200417 Substituted 4-amino-isoquinoline compounds, pharmaceutical composition and method of use |
| 04/06/1993 | US5200416 Cyclic amides |
| 04/06/1993 | US5200414 Methods for the treatment of cognitive disorders |
| 04/06/1993 | US5200412 Antiinflammatory agents and antiallergens |
| 04/06/1993 | US5200410 Medicaments for the treatment of cerebral apoplexy |
| 04/06/1993 | US5200405 Use of n-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders |
| 04/06/1993 | US5200404 Bactericides |
| 04/06/1993 | US5200402 Synergistic wound healing agent |
| 04/06/1993 | US5200399 Mixing tissues, cells, organelles and/or biologically active compounds with vitrifying solutes, exposing mixture to desiccant to dry and storing |
| 04/06/1993 | US5200342 Squalene synthetase inhibitors and processes therefrom |
| 04/06/1993 | US5200329 An Isolating Compound Which is Useful in the Prevention or Tre atment of HIV Infection and the Treatment of AIDS |
| 04/06/1993 | US5200200 Administering redox acitve parenteral therapeutic solution |
| 04/06/1993 | US5200198 Medicament and its production and use in the treatment of pain, inflammation and fever in man and animals |
| 04/06/1993 | US5200197 Contraceptive pill |
| 04/06/1993 | US5200193 Pharmaceutical sustained release matrix and process |
| 04/06/1993 | US5200192 Containing polyoxyalkylene glycol and polyoxyethylene glycol ester component |
| 04/06/1993 | US5200190 Estradiol dissolved in adhesive base: copolymer of 2-ethylhexyl acrylate and N-vinyl-2-pyrrolidone; flexible tape backing; impermeable to active ingredient |
| 04/06/1993 | US5199375 Folding warning marker |
| 04/06/1993 | CA1315803C N-alkoxyalkylamides of hydroxyacids and skin treating compositions therewith |
| 04/06/1993 | CA1315793C Method for controlling emesis caused by chemotherapeutic agents and antiemetic carboxamides useful therein |
| 04/06/1993 | CA1315791C Oxathiolanes |
| 04/06/1993 | CA1315790C Method of improving sleep |
| 04/06/1993 | CA1315787C Morpholine compounds and methods of use |
| 04/06/1993 | CA1315786C Imidazoquinoxaline compounds and their preparation and use |
| 04/06/1993 | CA1315784C Heteroaryloxy-.beta.-carboline derivatives, their preparation and their use as medicinal agents |
| 04/06/1993 | CA1315781C 1,4-diazepine derivatives having anti-ulcer activity |
| 04/06/1993 | CA1315779C Aristeromycin/adenosine derivatives |
| 04/06/1993 | CA1315778C Polyhydroxylated and highly fluorinated compounds, their preparation and their use as surfactants |
| 04/06/1993 | CA1315776C Process for the production of o , 2'-anhydro-1- (.beta.-d-arabinofurano syl)thymine |
| 04/06/1993 | CA1315775C 4-demethoxy-4-amino-anthracyclines |
| 04/06/1993 | CA1315774C Anthraline-sterol complexes, their production process and their use as therapeutics and cosmetics |
| 04/06/1993 | CA1315717C Nucleic acid derivatives |
| 04/06/1993 | CA1315693C Process and composition for oral hygiene |
| 04/06/1993 | CA1315692C Pharmaceutical compositions for topical application with systemic action |
| 04/06/1993 | CA1315691C Therapeutic agents containing enantiomers of propafenone |
| 04/06/1993 | CA1315690C Synergistic combination of decarboxylase inhibitors and l-dopa pellets |
| 04/06/1993 | CA1315689C Quarternary derivatives of noroxymorphone which relieve nausea and emesis |
| 04/06/1993 | CA1315688C Compositions and methods for improving cold tolerance in animals and humans |
| 04/06/1993 | CA1315687C Dosage form for dispensing drug for human therapy |
| 04/06/1993 | CA1315686C Pharmaceutical compositions containing at least one naphtylaromatic compound as an active ingredient |
| 04/06/1993 | CA1315685C Pharmaceutical compositions based on benzoic benzopyranyl and benzothiopyranyl compounds |
| 04/06/1993 | CA1315684C Anti-retroviral agents and delivery system for the same |
| 04/06/1993 | CA1315682C Injection containing 3-benzoyloxy-1,3,5(10)-estratriene -17-¬4- p-(bis(2-chloroethyl)amino)phenyl -butanoyloxy| acetate as an active |
| 04/06/1993 | CA1315681C Tablet for use in the treatment of progesterone deficiency |
| 04/06/1993 | CA1315680C Sustained-release multi-granule tablet |
| 04/06/1993 | CA1315678C Alpha-tocopherol based vesicles |
| 04/06/1993 | CA1315677C Use of epidermal growth factor |
| 04/06/1993 | CA1315674C Pharmaceutical compositions containing at least one bicyclic aromatic derivative as an active ingredient |
| 04/05/1993 | WO1993006823A1 Verbenone, having antielastase activity, against pulmonary emphysema |
| 04/05/1993 | CA2097611A1 Verbenone, having antielastase actibity, against pulmonary emphysema |
| 04/05/1993 | CA2079735A1 Acylals of imidazole-5-carboxylic acid derivatives, process for their preparation and their use |
| 04/05/1993 | CA2079642A1 Medicament |
| 04/03/1993 | CA2079658A1 Dry eye treatment process and solution |
| 04/03/1993 | CA2079412A1 5-nitro-1-methyl-imidazolyl-3-terbutyl-2- hydroxy-aryl-carbinols, a process for their preparation and relative therapeutical compositions |
| 04/03/1993 | CA2052637A1 Pharmaceutical preparation having an improved absorption property |
| 04/02/1993 | CA2079420A1 Pharmaceutical composition containing felbinac |